journal article·2026-07-14Open access

PEAR1 Promotes Glucose Metabolism Reprogramming in Sepsis‐Associated Acute Lung Injury via AARS1‐Mediated HIF‐1α Lactylation

Shuai Li, Zongqing Lu, Pu Fang, Qingqing Pang, Xianghui Wu, Bo Wang, Min Liang, Jingjing Pan, Haobo Kong, Haijian Cai, Juanjuan Li, Jiaying Kang, Dongsheng Wang, Dunling Xia, Mengmeng Xu, Qinghai You

Abstract

ABSTRACT Sepsis‐associated acute lung injury (S‐ALI), in which pulmonary microvascular endothelial cells act as key drivers of disease progression by increasing vascular permeability and ultimately exacerbating lung injury, is associated with a high mortality rate. Here, we report that PEAR1 expression and vascular permeability are increased in the lung tissues of septic mice. Pear1 knockdown markedly reduces pulmonary vascular permeability and consequently attenuates lung injury in septic mice. Mechanistically, PEAR1 promotes the AARS1‐mediated lactylation of HIF‐1α, primarily at lysine 172 (K172). This lactylation event, in turn, increases the affinity of HIF‐1α for importin α, thereby facilitating HIF‐1α nuclear translocation. Importantly, HIF‐1α K172 lactylation promotes glycolysis, and glycolysis‐derived lactate further drives H3K18 lactylation. In addition, this lactate‐dependent histone modification is enriched at the Pear1 promoter, resulting in further increases in glycolysis and pulmonary vascular permeability. In vivo, both Pear1 knockout and the targeted delivery of Pear1 siRNA to inflammatory vascular endothelial cells using E‐selectin‐binding peptide‐modified liposomes ameliorate ALI, and improve survival in mice with polymicrobial sepsis. Our study identifies K172 as a previously unreported lactylation site on HIF‐1α and shows that PEAR1 promotes AARS1‐mediated HIF‐1α lactylation, enhances glycolysis, and increases H3K18la enrichment at the Pear1 promoter, thereby forming a positive feedback loop.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer, Hypoxia, and Metabolism · Hyperglycemia and glycemic control in critically ill and hospitalized patients · Mitochondrial Function and Pathology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Respiratory and Critical Care Medicine The First Affiliated Hospital of Anhui Medical University Hefei China

Department of Intensive Care Unit The First Affiliated Hospital of Anhui Medical University Hefei China

Department of Respiratory Intensive Care Unit Anhui Chest Hospital Hefei China

Center For Scientific Research Anhui Medical University Hefei China

Department of Pulmonary and Critical Care Medicine, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC University of Science and Technology of China Hefei China

Department of Emergency Medicine The First Affiliated Hospital of Anhui Medical University Hefei China

Laboratory of Structural Immunology, National Key Laboratory of Immune Response and Immunotherapy, Division of Life Sciences and Medicine University of Science and Technology of China Hefei China

Anhui Provincial Key Laboratory of Geriatric Immunotherapy and Nutrition Therapy, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC University of Science and Technology of China Hefei China

Funding

National Natural Science Foundation of China

References (58)

Show source-provided references
1. 10.1016/S0140-6736(19)32989-710.1016/S0140-6736(19)32989-7 ↗
2. 10.1001/jama.2016.028710.1001/jama.2016.0287 ↗
3. 10.1155/2022/636234410.1155/2022/6362344 ↗
4. 10.1016/j.redox.2023.10265510.1016/j.redox.2023.102655 ↗
5. 10.1186/s13054-024-04875-610.1186/s13054-024-04875-6 ↗
6. 10.1074/jbc.M41341120010.1074/jbc.M413411200 ↗
7. 10.1371/journal.pone.013879510.1371/journal.pone.0138795 ↗
8. 10.1093/cvr/cvv19310.1093/cvr/cvv193 ↗
9. 10.1016/j.mvr.2019.10394110.1016/j.mvr.2019.103941 ↗
10. 10.1038/s41467‐022‐34870‐w10.1038/s41467‐022‐34870‐w ↗
11. 10.1016/j.cell.2013.06.03710.1016/j.cell.2013.06.037 ↗
12. 10.1152/physrev.00001.201710.1152/physrev.00001.2017 ↗
13. 10.1126/sciadv.abm896510.1126/sciadv.abm8965 ↗
14. 10.1097/SHK.000000000000198310.1097/SHK.0000000000001983 ↗
15. 10.1186/s40779-022-00381-410.1186/s40779-022-00381-4 ↗
16. 10.1002/mco2.7004910.1002/mco2.70049 ↗
17. 10.1002/advs.20250240210.1002/advs.202502402 ↗
18. 10.1038/s41467‐023‐35795‐810.1038/s41467‐023‐35795‐8 ↗
19. 10.1038/s41586‐019‐1678‐110.1038/s41586‐019‐1678‐1 ↗
20. 10.1016/j.cmet.2023.12.02310.1016/j.cmet.2023.12.023 ↗
21. 10.1016/j.redox.2024.10319410.1016/j.redox.2024.103194 ↗
22. 10.1016/j.immuni.2024.04.00610.1016/j.immuni.2024.04.006 ↗
23. 10.1161/CIRCRESAHA.122.32048810.1161/CIRCRESAHA.122.320488 ↗
24. 10.1016/j.cmet.2023.06.01310.1016/j.cmet.2023.06.013 ↗
25. 10.1002/advs.20240706410.1002/advs.202407064 ↗
26. 10.1038/s41467‐023‐42634‐310.1038/s41467‐023‐42634‐3 ↗
27. 10.1038/s41419‐024‐06446‐710.1038/s41419‐024‐06446‐7 ↗
28. 10.1007/s10142‐024‐01483‐z10.1007/s10142‐024‐01483‐z ↗
29. 10.1038/s41420‐023‐01390‐510.1038/s41420‐023‐01390‐5 ↗
30. 10.1016/0092‐8674(84)90457‐410.1016/0092‐8674(84)90457‐4 ↗
31. 10.4161/cc.2537910.4161/cc.25379 ↗
32. 10.1016/j.bbamcr.2007.12.00610.1016/j.bbamcr.2007.12.006 ↗
33. 10.1016/j.bbrc.2023.02.03610.1016/j.bbrc.2023.02.036 ↗
34. 10.1016/j.cbi.2025.11176010.1016/j.cbi.2025.111760 ↗
35. 10.1002/advs.20230567710.1002/advs.202305677 ↗
36. 10.1186/s43556‐025‐00275‐610.1186/s43556‐025‐00275‐6 ↗
37. 10.3389/fmolb.2024.151097510.3389/fmolb.2024.1510975 ↗
38. 10.1038/s41586‐024‐07992‐y10.1038/s41586‐024‐07992‐y ↗
39. 10.1016/j.cell.2024.04.00210.1016/j.cell.2024.04.002 ↗
40. 10.1093/burnst/tkaf05610.1093/burnst/tkaf056 ↗
41. 10.1016/j.ymthe.2020.01.02110.1016/j.ymthe.2020.01.021 ↗
42. 10.2147/IJN.S44272710.2147/IJN.S442727 ↗
43. 10.1002/advs.20250242810.1002/advs.202502428 ↗
44. 10.1038/s41419‐019‐2087‐y10.1038/s41419‐019‐2087‐y ↗
45. 10.1007/s10495‐023‐01847‐z10.1007/s10495‐023‐01847‐z ↗
46. 10.1055/s-0039-168399610.1055/s-0039-1683996 ↗
47. 10.1111/all.1636110.1111/all.16361 ↗
48. 10.7150/ijbs.7730410.7150/ijbs.77304 ↗
49. 10.1016/j.intimp.2025.11519810.1016/j.intimp.2025.115198 ↗
50. 10.1038/emm.2004.110.1038/emm.2004.1 ↗
51. 10.1016/j.redox.2021.10204710.1016/j.redox.2021.102047 ↗
52. 10.1126/sciadv.adc946510.1126/sciadv.adc9465 ↗
53. 10.1002/advs.20230721610.1002/advs.202307216 ↗
54. 10.1038/s41418‐021‐00841‐910.1038/s41418‐021‐00841‐9 ↗
55. 10.1002/advs.20230803110.1002/advs.202308031 ↗
56. 10.1016/j.redox.2024.10347910.1016/j.redox.2024.103479 ↗
57. 10.1164/rccm.202303‐0558WS10.1164/rccm.202303‐0558WS ↗
58. 10.1097/00003246-199711000-0003010.1097/00003246-199711000-00030 ↗